PepGen Inc. SEC filings PEPG
PepGen Inc. has 304 filings in SEC EDGAR's recent list, going back to Dec 9, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 21, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 4, 2026 | Mar 4, 2026 |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 7, 2025 | Nov 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 26, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 24, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 28, 2025 | May 28, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 31, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Other events
|
Mar 4, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 24, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Other events
|
Jan 29, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Other events
|
Oct 8, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 19, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Other events
|
Aug 20, 2024 | Aug 20, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 30, 2024 | Jul 30, 2024 |
| 8-K |
Current report
Other events
|
Jul 2, 2024 | Jul 2, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Jun 11, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Mar 15, 2024 | Mar 15, 2024 |
| 8-K |
Current report
Other events
|
Mar 13, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Other events
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Other events
|
Feb 20, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 7, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Other events
|
Jan 17, 2024 | Jan 17, 2024 |
| 8-K |
Current report
Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Other events
|
Dec 18, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 15, 2023 | Nov 15, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2023 | Nov 8, 2023 |
| 8-K |
Current report
Other events
|
Oct 12, 2023 | Oct 12, 2023 |
| 8-K |
Current report
Other events
|
Sep 6, 2023 | Sep 6, 2023 |
| 8-K |
Current report
Other events
|
Sep 6, 2023 | Sep 6, 2023 |
| 8-K |
Current report
Material agreement
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Other events
|
Jun 13, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Other events
|
May 30, 2023 | May 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 18, 2023 | May 18, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Other events
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Other events
|
Dec 7, 2022 | Dec 7, 2022 |
| 8-K |
Current report
Other events
|
Nov 14, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 22, 2022 | Sep 20, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2022 | Aug 12, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 22, 2022 | Jul 22, 2022 |
| 8-K |
Current report
Results of operations
|
Jun 16, 2022 | Jun 16, 2022 |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PEPG (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1835597
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.